Takeda Establishes Center Of Excellence In Singapore

Takeda Pharmaceuticals has entered into a multi-year partnership with the Singapore Economic Development Board to support the recruitment and training of local talent for vaccine process optimization.

Takeda Receives US$38 Million Polio Eradication Grant From Gates Foundation

With this funding, Takeda will develop, license and supply at least 50 million doses of a polio vaccine per year to more than 70 developing countries.

CFDA Approves First Inactivated Sabin Vaccine

The locally produced vaccine will aid China's efforts in polio eradication.

For Polio, Two Vaccines Are Better Than One

Although the injected polio vaccine is currently not favored in the developing world, a study shows that it could be used to enhance the protection of the oral vaccine.